MAM
AMPE

Meeder Asset Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Meeder Asset Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-16
Closed -$2K – 1924
2018
Q4 		$2K Buy
16
+14
+700% +$2.15K ﹤0.01% 1596
2018
Q3 		$0 Buy
+2
New +$836 ﹤0.01% 1740
2018
Q1 		– Sell
-2
Closed -$2K – 1799
2017
Q4 		$2K Sell
2
-9
-82% -$4.23K ﹤0.01% 1523
2017
Q3 		$2K Buy
11
+2
+22% +$317 ﹤0.01% 1499
2017
Q2 		$1K Sell
9
-12
-57% -$2.43K ﹤0.01% 1578
2017
Q1 		$5K Sell
21
-6
-22% -$1.61K ﹤0.01% 1113
2016
Q4 		$7K Buy
+27
New +$6.43K ﹤0.01% 822

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Meeder Asset Management's AMPE Position: Q1 2019 in Review

Meeder Asset Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2019, closing a stake of 16 shares — an estimated $2K sold.

Meeder Asset Management first reported a position in AMPE in Q4 2016 and held it in 7 quarters. The position peaked at $7K in Q4 2016. 84 funds tracked by Wall St. Rank hold AMPE as of Q1 2019.

  • Meeder Asset Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2019 after selling out during the quarter.
  • Meeder Asset Management sold 16 Ampio Pharmaceuticals Inc. shares in Q1 2019, an estimated $2K.
  • Meeder Asset Management first reported a position in Ampio Pharmaceuticals Inc. in Q4 2016 and held it in 7 quarters.
  • Meeder Asset Management's Ampio Pharmaceuticals Inc. position peaked at $7K in Q4 2016.
  • 84 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2019.

Based on Meeder Asset Management's 13F filing for Q1 2019, filed 16 Apr 2019.